Boston Scientific anounces primary endpoint results of NECTAR-HF clinical trial
Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation for the treatment of heart failure patients. August 30, 2014